Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2009
12/30/2009CA2729436A1 Pyrazolo-quinazolines
12/30/2009CA2729420A1 Combination of amidine derivates with cyclic depsipeptides
12/30/2009CA2729327A1 Organic compounds
12/30/2009CA2729275A1 5- and 6-membered heterocyclic compounds
12/30/2009CA2729259A1 1,2-disubstituted heterocyclic compounds
12/30/2009CA2729257A1 Schweinfurthin analogues
12/30/2009CA2729227A1 2-heterocyclylaminoalkyl-(p-quinone) derivatives for treatment of oxidative stress diseases
12/30/2009CA2729220A1 Di-substituted phenyl compounds
12/30/2009CA2729217A1 6-substituted phenoxychroman carboxylic acid derivatives
12/30/2009CA2729115A1 Substituted triazinone derivatives
12/30/2009CA2729108A1 Organic compounds
12/30/2009CA2729057A1 3-cyanoalkyl- and 3-hydroxyalkylindoles and use thereof
12/30/2009CA2729052A1 Salts of methyl 2-((r)-(3-chlorophenyl)((r)-1-((s)-2-(methylamino)-3((r)-tetrahydro-2h-pyran-3-yl)propylcarbamoyl)piperidin-3-yl)methoxy)ethylcarbamate
12/30/2009CA2729050A1 Diaryl ureas for treating heart failure
12/30/2009CA2729048A1 Substituted 7-sulfanylmethyl, 7-sulfinylmethyl and 7-sulfonylmethyl indoles and use thereof
12/30/2009CA2729041A1 Diaryl urea for treating heart failure
12/30/2009CA2729034A1 Use
12/30/2009CA2729016A1 Piperidinyl derivative as a modulator of chemokine receptor activity
12/30/2009CA2728852A1 Pharmaceutical composition comprising n-[2-(diethylamino)ethyl]-5-[(5-fluoro-1,2-dihydro-2-oxo-3h-indol-3-ylidene)methyl]-2,4-dimethyl-1h-pyrrole-3-carboxamide
12/30/2009CA2728851A1 Thiazolylpiperidine derivatives
12/30/2009CA2728806A1 Squaric acid derivatives as inhibitors of the nicotinamide phosphoribosyltransferase
12/30/2009CA2728767A1 Alkynyl alcohols as kinase inhibitors
12/30/2009CA2728730A1 Novel tetramethyl substituted piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
12/30/2009CA2728728A1 Substituted tricyclic derivatives
12/30/2009CA2728727A1 Pharmaceutical transdermal compositions and method for treating inflammation in cattle
12/30/2009CA2728696A1 Substituted pyrimidin-4-one derivatives
12/30/2009CA2728695A1 Substituted alkyl pyrimidin-4-one derivatives
12/30/2009CA2728694A1 Substituted pyrimidone derivatives
12/30/2009CA2728693A1 Substituted pyrimido [2, 1-a] isoquinolin-4-one derivatives
12/30/2009CA2728680A1 Substituted n-oxide pyrazine derivatives
12/30/2009CA2728652A1 Use of cyclolignans for the treatment of a hyperactive immune system
12/30/2009CA2728539A1 Pharmaceutical compositions of rosuvastatin calcium
12/30/2009CA2728511A1 Sulfonamide compounds or salts thereof
12/30/2009CA2728283A1 Isoquinolinone derivatives as nk3 antagonists
12/30/2009CA2728161A1 Therapeutic agent for inflammatory bowel disease
12/30/2009CA2728137A1 Substituted isoquinolines and isoquinolinones as rho kinase inhibitors
12/30/2009CA2728128A1 6-substituted isoquinolines and isoquinolinones
12/30/2009CA2728123A1 Bi- and polycyclic substituted isoquinoline and isoquinolinone derivatives
12/30/2009CA2728112A1 Pharmaceutical composition and extract of poria for treating a disease induced from immune disorder
12/30/2009CA2728089A1 Therapeutic agent for spinal canal stenosis
12/30/2009CA2728016A1 Novel substituted pyridin-2-ones and pyridazin-3-ones
12/30/2009CA2727925A1 New heterocyclic carboxamides for use as thrombin inhibitors
12/30/2009CA2727737A1 Materials and methods for suppressing and/or treating neurofibroma and related tumors
12/30/2009CA2727573A1 Diaryl compounds and uses thereof
12/30/2009CA2727455A1 Heteroaryl compounds and uses thereof
12/30/2009CA2727444A1 Triazolo [4,5-d] pyramidine derivatives and their use as purine receptor antagonists
12/30/2009CA2727340A1 Carboxylic acid compound
12/30/2009CA2727197A1 Composition of flavanolignan and amino acid with improved water solubility
12/30/2009CA2726996A1 Method and compositions for improving skin and body appearance
12/30/2009CA2726836A1 Dermal delivery
12/30/2009CA2726834A1 5,6,7,8-tetrahydro-imidazo[1,5-a]pyrazine compounds
12/30/2009CA2726291A1 Combination of a nicotinic receptor partial agonist and of an acetylcholinesterase inhibitor, pharmaceutical composition containing same and use thereof in the treatment of cognitive disorders
12/30/2009CA2725930A1 Methods for treating visceral fat conditions
12/30/2009CA2723435A1 Novel depigmenting compositions in the form of a petroleum jelly-free and elastomer-free anhydrous composition comprising a solubilized phenolic derivative and a retinoid
12/30/2009CA2723342A1 Novel anhydrous depigmenting compositions comprising a solubilized phenolic derivative
12/30/2009CA2723341A1 Novel depigmenting compositions in the form of a petroleum jelly-free and elastomer-free anhydrous composition comprising a solubilized phenolic derivative
12/30/2009CA2723313A1 Anhydrous depigmenting compositions comprising, within the fatty phase, a solubilized phenolic derivative and a retinoid
12/30/2009CA2722147A1 Pharmaceutical compositions comprising aminocyclohexane derivatives
12/30/2009CA2695590A1 Method of efficiently establishing induced pluripotent stem cells
12/29/2009USRE41065 Such as (6,7-dimethoxyquinazolin-4-yl)-(3-ethynylphenyl)-amine for treatment of hyperproliferative diseases
12/29/2009US7638651 Substituted cyclohexanones
12/29/2009US7638643 Process for producing soybean saponin-containing material
12/29/2009US7638640 total pomegranate tannins (TPT) including punicalagin; nutraceutical for cardiovascular health
12/29/2009US7638639 Substituted pyrrolidine and related compounds
12/29/2009US7638638 Antiinflamamtory agents; autoimmune disease; immunosuppressants;multiple sclerosis; antiarthritic agents
12/29/2009US7638637 Orally available sphingosine 1-phosphate receptor agonists and antagonists
12/29/2009US7638630 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses as VLA-4 inhibitors
12/29/2009US7638629 4-Isopropylphenyl)-2-[4-(trifluoromethyl)phenyl]piperidin-4-yl}acetic acid; modulators of gamma secretase isoforms, 1-42; antifibrillatory agents; neurodegenerative diseases; modulating activity of gamma -secretase as opposed to suppressing it to reduced risk of side effects; beta secretase inhibitors
12/29/2009US7638624 Antiinflammatory agents; autoimmune diseases; antiproliferative agents; using benzodiazepine compound
12/29/2009US7638623 Galactoside inhibitors of galectins
12/29/2009US7638620 Use to enhance apoptosis; antiproliferative agents
12/29/2009US7638601 Transient receptor potential channel TRPM8 and its use
12/29/2009US7638598 ErbB interface peptidomimetics and methods of use thereof
12/29/2009US7638557 17-phenyl trinor PGF2 alpha cyclopropylmethyl amide, for example; stimulates hair growth of scalp, eyebrows or eyelashes or restores hair color to depigmented hair
12/29/2009US7638556 Freeze-dried product of N-[o-(p-pivaloyloxy benzenesulfonylamino)benzoyl]glycine monosodium salt tetra-hydrate and a process for the manufacture thereof
12/29/2009US7638555 hydrolyzing titanium alkoxide in a reverse micelle solution of highly-dispersed nano-droplets of an organic continuous phase, a nonionic surfactant, and water to form a TiO2-containing solution; dip coating it on a substrate; drying and calcining; used for for killing bacteria and viruses in UV radiation
12/29/2009US7638553 Hydroxamates, their manufacture and use as pharmaceutical agents
12/29/2009US7638552 administering 1 mg to about 10 mg of glycopyrrolate while fasting
12/29/2009US7638551 Amino alcohol compounds or phosphonic acid derivatives thereof
12/29/2009US7638550 new compounds derived from formula I pyrroles, methods for obtaining them and their application as drugs in pharmaceutical compositions for the treatment of cancer due to their inhibitory activity on certain histone deacetylases.
12/29/2009US7638549 Mitotic kinesin inhibitors
12/29/2009US7638548 Spiroindolinone derivatives
12/29/2009US7638546 Imidazolyl derivatives
12/29/2009US7638545 Anthelmintic composition
12/29/2009US7638544 2-Methylamino-N-{2-(6-{1-methyl-2-(2-methylamino-propionylamino)-3-oxo-3-[2-(5-phenoxy-tetrazol-1-ylmethyl)-pyrrolidine-1-yl]-propoxy}-hexa-2,4-diynyloxy)-1-[2-(5-phenoxy-tetrazol-1-ylmethyl)-pyrrolidine-1-carbonyl]-propyl}-propionamide; mimetics of second mitochondria-derived activator of caspases
12/29/2009US7638543 Cystic fibrosis transmembrane conductance regulator protein inhibitors and uses thereof
12/29/2009US7638542 Method of obtaining 2-amino-6-alkyl-amino-4,5,6,7-tetrahydro-benzothiazoles
12/29/2009US7638541 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine
12/29/2009US7638540 Benzofuran compound and medicinal composition containing the same
12/29/2009US7638539 5-(4-{2-[5-methyl-2-(4-trifluoromethyl-phenyl)-thiazol -4-yl]-ethoxy}-phenyl)-3H-[1,3,4] oxadiazol-2-one; treatment of demyelinating diseases and disorders of fatty acid metabolism and glucose utilization such as multiple scleroses
12/29/2009US7638538 4-chloro-N-({5-[({2-[(2-{[3-chloro-5-(trifluoromethyl)pyridin-2-yl]amino}ethyl)amino]-2-oxoethyl}amino)sulfonyl]thien-2-yl}methyl)benzamide; inhibitor of jun N-terminal kinase 2 and 33 inhibitor; autoimmune disorders
12/29/2009US7638537 Pyrazole compounds as transforming growth factor (TGF) inhibitors
12/29/2009US7638536 N-[4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)thiazol-2-yl]-3-fluoro-4-hydroxybenzamide; nonpeptide c-mpl ligand; low immunogenicity; proliferate human c-mpl-Ba/F3 cells; increase platelets by promoting the formation of megakaryocytic colonies; orally
12/29/2009US7638535 (3S)-trans)-8-methyl-3,4-dihydro-2H-benzo[b][1,4]dioxepine-6-carboxylic acid [3-hydroxy-1-(3-methoxy-propyl)-piperidin-4-ylmethyl]-amide; hypermotility, irritable bowel syndrome, constipation or diarrhea predominant IDS, pain and non-pain predominant IBS and bowel hypersensitivity
12/29/2009US7638534 Use of indazole derivatives for the treatment of neuropathic pain
12/29/2009US7638533 Dihydro-1[1H]-quinolin-2-one derivatives as RXR agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes
12/29/2009US7638532 exo-3-(3 ,4-Dichloro-phcnoxy)-8-aza-bicyclo[3.2.1]oct-6-ene; antidepressants, psychological disorders
12/29/2009US7638531 use in treating inflammatory diseases, allergic conditions, diabetes, obesity, an obesity-related disorder, metabolic syndrome, a cognition deficit disorder, cardiovascular and central nervous system disorders
12/29/2009US7638530 1-{1-[4-(3-amino-5-phenyl-1H-pyrazolo[3,4-b]pyridin-6-yl)benzyl]piperidin-4-yl}-1,3-dihydro-2H-benzimidazol-2-one; anticarcinogenic agents
12/29/2009US7638529 Heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents
1 ... 2440 2441 2442 2443 2444 2445 2446 2447 2448 2449 2450 2451 2452 2453 2454 2455 2456 2457 2458 2459 2460 ... 7860